MEDP 241220 340.00C (MEDP241220C340000) Stock Options, News & Quotes

US OptionsDetailed Quotes

MEDP241220C340000

Watchlist

10.40
-4.44-29.92%

15min DelayClose Nov 27 16:00 ET

10.40High10.40Low

Intraday

5D
Daily

News

Is It Time To Consider Buying Medpace Holdings, Inc. (NASDAQ:MEDP)?
Simply Wall StNov 25 08:47 ET
Medpace Holdings Is Maintained at Neutral by Baird
Dow JonesNov 25 08:01 ET · Ratings
Medpace Hldgs Analyst Ratings
BenzingaNov 25 07:48 ET · Ratings
Baird Maintains Medpace(MEDP.US) With Hold Rating, Raises Target Price to $354
Moomoo NewsNov 25 07:31 ET · Ratings
Medpace Price Target Raised to $354 From $349 at Baird
TipRanksNov 25 07:20 ET
Express News | Medpace Holdings Inc : Baird Raises Target Price to $354 From $349
ReutersNov 25 00:25 ET

Comments

Kevin Travers

Oct 22 15:31

Columns Market Falls For Second Day Tuesday | Wall Street Today

The market fell Tuesday after consumer and communications earnings came in mixed. Investors awaiting $Tesla (TSLA.US)$ earnings Wednesday to see if indexes keep growing to all-time highs.
After 4 pm ET, the $S&P 500 Index (.SPX.US)$ fell 0.05%, the $Dow Jones Industrial Average (.DJI.US)$ fell 0.02%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.17%.
MACRO
Senior Federal Reserve official Mary Daly said. Economic growth and the labor ma...

Gold prices hit new highs again! How should we allocate various assets?

Moomoo AI

Mar 22 08:59

Investors expect Medpace Holdings to outperform the market, hence its high P/E ratio. Strong future growth anticipation makes investors pay more for the stock, supporting the share price.

The Price Is Right For Medpace Holdings, Inc. (NASDAQ:MEDP)

Moomoo AI

Feb 21 05:52

Medpace Holdings' robust conversion of profit to free cash flow is promising. Its underlying earnings potential may even surpass the statutory profit. Its earnings per share have seen a remarkable growth over the past three years.

Medpace Holdings' (NASDAQ:MEDP) Earnings Seem To Be Promising

Moomoo AI

Feb 19 08:35

Medpace Holdings' market sentiment remains steady, mirroring EPS growth. The stock's recent performance shows improvement, with a 90% shareholder return over the last year, surpassing the five-year TSR of 41% per year. The strong share price momentum suggests a closer look at the stock may be worthwhile.

Medpace Holdings (NASDAQ:MEDP) Jumps 21% This Week, Though Earnings Growth Is Still Tracking Behind Five-year Shareholder Returns

Moomoo AI

Dec 20, 2023 07:21

Medpace's high P/E is backed by its forecast growth being higher than the wider market. Investors are quite confident in the company's future earnings and seem willing to pay more for the stock, suggesting a bullish outlook.

Medpace Holdings, Inc.'s (NASDAQ:MEDP) Earnings Haven't Escaped The Attention Of Investors